Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
6
×
biotech
6
×
boston blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
6
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
fda
abbvie
bristol-myers squibb
cancer
cancer immunotherapy
eli lilly
novartis
startups
alzheimer's disease
astrazeneca
deals
What
bio
6
×
roundup
biotech
days
drug
ipo
news
week
acquisitions
alliance
alzheimer’s
america
announced
annual
approval
assessed
attention
august
biogen
biogen’s
biopharmaceutical
bristol
busy
buy
calls
ceo
changing
collabs
color
communities
companies
conference
continues
convo
convoluted
covid
crispr
daniel
deal
decisions
Language
unset
Current search:
bio
×
biotech
×
" clinical trials "
×
biogen
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More